ADDISON, Texas, Sept. 21 /PRNewswire-FirstCall/ -- The Regents of the
University of California, under its United States Department of Energy
(DOE) contract to manage and operate Lawrence Livermore National Laboratory
(LLNL) and CDT Systems, Inc. (OTC Bulletin Board: CDTN), have executed an
additional license under patent rights whereby CDT Systems will have rights
to manufacture and market Carbon Aerogel worldwide, except for capacitor
fields of use.
This second LLNL license specifically authorizes CDT Systems to
manufacture Carbon Aerogel for use as an electrode for the generation of
hydrogen from water by hydrolysis and the development of proprietary
variable pore-size Carbon Aerogel electrodes.
CDT Systems currently has a patent license agreement with LLNL for
Capacitive Deionization Technology for brackish water/sea water
desalination and treatment of heat exchanger and boiler water, industrial
and commercial process water and ultrapure industrial water.
CDT Systems' manufacturing facility is scheduled to initially produce
80,000 square feet of proprietary Carbon Aerogel electrodes per month.
Current Carbon Aerogel applications include brackish water desalination,
industrial and coalbed methane groundwater water remediation, hydrogen
generation and Carbon Aerogel for CDT Systems' alliance partners'
The Company is the nonexclusive business, technology licensee, and
manufacturing associate of the U.S. Department of Energy's Lawrence
Livermore National Laboratory ("LLNL") for the development and
commercialization of Carbon Aerogel material sciences-based capacitive
deionization technology (CDT) for water purification, as well as Carbon
Aerogel for hydrogen generation, insulation, including fuel cells and
Statements about CDT's outlook and all other statements in this release
other than historical facts are forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. These
forward-looking statements rely upon a number of assumptions concerning
future events and are subject to a number of uncertainties and other
factors outside CDT's control, which could cause actual results to differ
materially from such statements. While CDT believes that the assumptions
concerning future events are reasonable, it cautions that there are
inherent difficulties in predicting certain important factors that could
impact the future performance. Among the important factors that could cause
actual results to differ materially are the completion of the manufacturing
facility and the demand for CDT's products. These and other risk factors
are discussed in CDT's filings with the Securities and Exchange Commission,
copies of which are available to the public. CDT expressly disclaims any
intention or obligation to revise or update any forward-looking statements
whether as a result of new information, future events, or otherwise.
Contact Information: Mr. Dallas Talley, CEO, Capacitive Deionization
Technology Systems, Inc. (CDT Systems), Addison, Texas, phone (972)
934-1586; e-mail: email@example.com
SOURCE CDT Systems, Inc.